Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammaplasty | 22 | 2021 | 1204 | 4.020 |
Why?
|
| Breast Implantation | 10 | 2021 | 218 | 3.070 |
Why?
|
| Mastectomy | 19 | 2021 | 1793 | 2.170 |
Why?
|
| Tissue Expansion | 5 | 2021 | 162 | 1.410 |
Why?
|
| Breast Implants | 11 | 2021 | 387 | 1.370 |
Why?
|
| Surgical Flaps | 8 | 2019 | 1640 | 1.360 |
Why?
|
| Postoperative Complications | 12 | 2021 | 15297 | 0.820 |
Why?
|
| Breast Neoplasms | 20 | 2021 | 20824 | 0.800 |
Why?
|
| Nipples | 4 | 2021 | 219 | 0.730 |
Why?
|
| Surgical Wound Infection | 5 | 2017 | 1540 | 0.670 |
Why?
|
| Esthetics | 2 | 2017 | 306 | 0.590 |
Why?
|
| Thoracic Wall | 2 | 2016 | 203 | 0.520 |
Why?
|
| Rectus Abdominis | 2 | 2018 | 97 | 0.510 |
Why?
|
| Patient Satisfaction | 6 | 2018 | 3395 | 0.510 |
Why?
|
| Tissue Expansion Devices | 5 | 2019 | 156 | 0.490 |
Why?
|
| Seroma | 1 | 2013 | 71 | 0.460 |
Why?
|
| Collagen | 2 | 2021 | 2688 | 0.420 |
Why?
|
| Hodgkin Disease | 1 | 2020 | 1415 | 0.410 |
Why?
|
| Wound Healing | 2 | 2017 | 2785 | 0.400 |
Why?
|
| Radiotherapy, Adjuvant | 4 | 2019 | 1771 | 0.370 |
Why?
|
| Breast Cyst | 1 | 2009 | 8 | 0.340 |
Why?
|
| Hyperprolactinemia | 1 | 2009 | 129 | 0.310 |
Why?
|
| Sodium Chloride | 3 | 2016 | 625 | 0.260 |
Why?
|
| Follow-Up Studies | 11 | 2021 | 39052 | 0.260 |
Why?
|
| Epigastric Arteries | 2 | 2018 | 96 | 0.240 |
Why?
|
| Treatment Outcome | 14 | 2021 | 63107 | 0.240 |
Why?
|
| Milk, Human | 1 | 2009 | 490 | 0.240 |
Why?
|
| Carbon Dioxide | 3 | 2016 | 1150 | 0.230 |
Why?
|
| Middle Aged | 27 | 2021 | 213390 | 0.220 |
Why?
|
| Logistic Models | 5 | 2017 | 13409 | 0.210 |
Why?
|
| Retrospective Studies | 15 | 2020 | 77460 | 0.210 |
Why?
|
| Fat Necrosis | 2 | 2013 | 58 | 0.210 |
Why?
|
| Adult | 26 | 2021 | 214052 | 0.200 |
Why?
|
| Biocompatible Materials | 1 | 2010 | 1736 | 0.200 |
Why?
|
| Ischemia | 1 | 2010 | 1907 | 0.190 |
Why?
|
| Female | 32 | 2021 | 380193 | 0.180 |
Why?
|
| Facial Injuries | 2 | 2011 | 183 | 0.180 |
Why?
|
| Facial Transplantation | 2 | 2011 | 226 | 0.160 |
Why?
|
| Thyroglobulin | 1 | 1998 | 114 | 0.160 |
Why?
|
| Inflammatory Breast Neoplasms | 1 | 2019 | 143 | 0.150 |
Why?
|
| Dizocilpine Maleate | 1 | 2017 | 176 | 0.150 |
Why?
|
| Body Mass Index | 2 | 2012 | 12721 | 0.150 |
Why?
|
| Skin | 1 | 2010 | 4372 | 0.140 |
Why?
|
| Humans | 38 | 2021 | 744366 | 0.140 |
Why?
|
| Choline | 1 | 2017 | 493 | 0.130 |
Why?
|
| Reoperation | 2 | 2017 | 4201 | 0.130 |
Why?
|
| Carcinoma, Lobular | 1 | 2019 | 484 | 0.130 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2016 | 255 | 0.120 |
Why?
|
| Ginsenosides | 1 | 2013 | 11 | 0.120 |
Why?
|
| Explosions | 1 | 2013 | 109 | 0.110 |
Why?
|
| Surgery Department, Hospital | 1 | 2013 | 175 | 0.100 |
Why?
|
| Membrane Microdomains | 1 | 2013 | 203 | 0.100 |
Why?
|
| Thyroid Gland | 1 | 1998 | 1173 | 0.100 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2019 | 1100 | 0.100 |
Why?
|
| Time Factors | 4 | 2017 | 40075 | 0.100 |
Why?
|
| Aged | 12 | 2019 | 163288 | 0.100 |
Why?
|
| Prospective Studies | 6 | 2021 | 53290 | 0.100 |
Why?
|
| Burns, Electric | 1 | 2011 | 42 | 0.090 |
Why?
|
| Terrorism | 1 | 2013 | 211 | 0.090 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2013 | 437 | 0.090 |
Why?
|
| Cattle | 1 | 2016 | 3922 | 0.090 |
Why?
|
| Risk Factors | 5 | 2017 | 72296 | 0.090 |
Why?
|
| Blast Injuries | 1 | 2013 | 302 | 0.090 |
Why?
|
| Memory Disorders | 1 | 2017 | 1186 | 0.090 |
Why?
|
| Presenilin-1 | 1 | 2013 | 635 | 0.090 |
Why?
|
| Hernia, Abdominal | 1 | 2010 | 53 | 0.090 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2013 | 584 | 0.090 |
Why?
|
| Trans-Activators | 1 | 1998 | 2926 | 0.080 |
Why?
|
| Catgut | 1 | 2007 | 7 | 0.080 |
Why?
|
| Disaster Planning | 1 | 2013 | 549 | 0.080 |
Why?
|
| Memory | 1 | 2017 | 2174 | 0.080 |
Why?
|
| Surgical Mesh | 1 | 2010 | 276 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 1998 | 5867 | 0.070 |
Why?
|
| Postoperative Care | 1 | 2013 | 1487 | 0.070 |
Why?
|
| Surgery, Plastic | 1 | 2013 | 624 | 0.070 |
Why?
|
| Cohort Studies | 4 | 2017 | 40559 | 0.070 |
Why?
|
| Graft Rejection | 4 | 2016 | 4397 | 0.070 |
Why?
|
| Necrosis | 1 | 2010 | 1643 | 0.070 |
Why?
|
| Comorbidity | 2 | 2010 | 10388 | 0.070 |
Why?
|
| Thyroid Neoplasms | 1 | 1998 | 2282 | 0.060 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2017 | 2408 | 0.060 |
Why?
|
| Hippocampus | 1 | 2017 | 3675 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 2887 | 0.060 |
Why?
|
| Risk Assessment | 3 | 2017 | 23336 | 0.060 |
Why?
|
| Medical Records | 1 | 2010 | 1413 | 0.060 |
Why?
|
| Graft Survival | 2 | 2016 | 3737 | 0.060 |
Why?
|
| Health Status Indicators | 1 | 2010 | 970 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 1998 | 5856 | 0.060 |
Why?
|
| Young Adult | 5 | 2019 | 56429 | 0.060 |
Why?
|
| Incidence | 1 | 2021 | 20952 | 0.060 |
Why?
|
| Adolescent | 5 | 2017 | 85779 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12244 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 57776 | 0.050 |
Why?
|
| Radiography | 1 | 2013 | 7023 | 0.050 |
Why?
|
| Suture Techniques | 1 | 2007 | 798 | 0.050 |
Why?
|
| Low Back Pain | 1 | 2010 | 956 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 1998 | 9647 | 0.050 |
Why?
|
| Neoadjuvant Therapy | 1 | 2011 | 2727 | 0.040 |
Why?
|
| Genes, myc | 2 | 1998 | 399 | 0.040 |
Why?
|
| Transcription Factors | 1 | 1998 | 12207 | 0.040 |
Why?
|
| Paired Box Transcription Factors | 1 | 1998 | 214 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2010 | 9849 | 0.040 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1998 | 424 | 0.040 |
Why?
|
| Insufflation | 1 | 2016 | 65 | 0.040 |
Why?
|
| Neurotoxins | 1 | 2017 | 237 | 0.040 |
Why?
|
| Prognosis | 2 | 2019 | 29060 | 0.030 |
Why?
|
| United States | 2 | 2021 | 69872 | 0.030 |
Why?
|
| Genes, BRCA2 | 1 | 2017 | 618 | 0.030 |
Why?
|
| Transfection | 2 | 1998 | 5895 | 0.030 |
Why?
|
| Genes, BRCA1 | 1 | 2017 | 781 | 0.030 |
Why?
|
| Smoking | 1 | 2010 | 8987 | 0.030 |
Why?
|
| Age Factors | 1 | 2010 | 18373 | 0.030 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2013 | 127 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 1998 | 988 | 0.030 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2013 | 200 | 0.030 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2013 | 298 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 2013 | 499 | 0.030 |
Why?
|
| Cricetulus | 1 | 2013 | 818 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2019 | 3616 | 0.020 |
Why?
|
| Animals | 5 | 2017 | 168768 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 1998 | 6313 | 0.020 |
Why?
|
| Rosacea | 1 | 2011 | 49 | 0.020 |
Why?
|
| CHO Cells | 1 | 2013 | 1409 | 0.020 |
Why?
|
| Cricetinae | 1 | 2013 | 2475 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2013 | 739 | 0.020 |
Why?
|
| Gestational Age | 1 | 2016 | 3493 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 3130 | 0.020 |
Why?
|
| Motor Activity | 1 | 2017 | 2715 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2013 | 3702 | 0.020 |
Why?
|
| Erythrocyte Transfusion | 1 | 2011 | 565 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1997 | 2943 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 8300 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 3848 | 0.020 |
Why?
|
| Glucose | 1 | 1998 | 4398 | 0.020 |
Why?
|
| Pregnancy | 2 | 2017 | 29144 | 0.020 |
Why?
|
| Apoptosis | 2 | 1998 | 9724 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 1998 | 13035 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2011 | 4777 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2011 | 3480 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2013 | 2531 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2011 | 2278 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 9240 | 0.010 |
Why?
|
| Protein Binding | 1 | 2013 | 9384 | 0.010 |
Why?
|
| Boston | 1 | 2013 | 9312 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 9735 | 0.010 |
Why?
|
| Amyloid beta-Peptides | 1 | 2013 | 3587 | 0.010 |
Why?
|
| Quality of Life | 1 | 2021 | 12802 | 0.010 |
Why?
|
| Massachusetts | 1 | 2011 | 8662 | 0.010 |
Why?
|
| Aging | 1 | 2017 | 8664 | 0.010 |
Why?
|
| Deoxyglucose | 1 | 1998 | 337 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 11031 | 0.010 |
Why?
|
| Male | 4 | 2017 | 350115 | 0.010 |
Why?
|
| Glycolysis | 1 | 1998 | 829 | 0.010 |
Why?
|
| Neurons | 1 | 2013 | 9340 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1998 | 1213 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1997 | 4320 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 1998 | 1434 | 0.010 |
Why?
|
| Mice | 2 | 2013 | 81201 | 0.010 |
Why?
|
| Cell Division | 1 | 1997 | 4569 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 13693 | 0.000 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1998 | 2949 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1998 | 19233 | 0.000 |
Why?
|
| Rats | 1 | 1998 | 24252 | 0.000 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 1997 | 8432 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1997 | 11486 | 0.000 |
Why?
|
Concepts
(165)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(40)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_